Search Clinical Trials
583,492 trials
ID
Status
Phase
Title
Sponsor
NCT07572747
Aspirin Versus Clopidogrel in Chronic Coronary Syndrome in Arabian Gulf CountriesKhalid F AlhabibNot Yet RecruitingPhase 3
NCT07572747Not Yet Recruiting
Phase 3
Aspirin Versus Clopidogrel in Chronic Coronary Syndrome in Arabian Gulf Countrie...Khalid F Alhabib
NCT07573644
A Prospective Randomized Study Comparing the Safety of Percutaneous and Open Brachial Access in the Endovascular Treatment of Peripheral Arterial LesionUniversity Hospital, BrestNot Yet RecruitingNot Applicable
NCT07573644Not Yet Recruiting
Not Applicable
A Prospective Randomized Study Comparing the Safety of Percutaneous and Open Bra...University Hospital, Bres...
NCT07574073
CD20 Monoclonal Antibody Combined With BTK Inhibitor for the Treatment of Refractory Immune-related CytopeniaQi dengNot Yet RecruitingPhase 1
NCT07574073Not Yet Recruiting
Phase 1
CD20 Monoclonal Antibody Combined With BTK Inhibitor for the Treatment of Refrac...Qi deng
NCT07574320
Effect of Ramosetron in Patients With Diarrhea Predominant Irritable Bowel SyndromeMd. Aminul IslamNot Yet RecruitingPhase 4
NCT07574320Not Yet Recruiting
Phase 4
Effect of Ramosetron in Patients With Diarrhea Predominant Irritable Bowel Syndr...Md. Aminul Islam
NCT07572409
Application of Cardiophrenic Lymphadenectomy in Advanced Ovarian Cancer: A Single-Center Prospective Exploratory StudymanxiaxiaRecruitingNot Applicable
NCT07572409Recruiting
Not Applicable
Application of Cardiophrenic Lymphadenectomy in Advanced Ovarian Cancer: A Singl...manxiaxia
NCT07572396
Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients With High-Risk HPV (Hr-HPV) and Either (1) ASC-US or (2) Low-Grade Squamous Intraepithelial Lesions (LSIL)Amplexd Therapeutics, Inc.RecruitingPhase 2
NCT07572396Recruiting
Phase 2
Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients With High-Ri...Amplexd Therapeutics, Inc...
NCT07574151
Accessing the Clarity and Acceptability of Recruitment Materials for a Study on Thoracic Aortic Disease SurveillanceUniversity of NottinghamRecruiting
NCT07574151Recruiting
—
Accessing the Clarity and Acceptability of Recruitment Materials for a Study on...University of Nottingham
NCT07574190
A Mobile Web App Intervention to Promote Cervical Cancer ScreeningUniversity of South DakotaNot Yet RecruitingNot Applicable
NCT07574190Not Yet Recruiting
Not Applicable
A Mobile Web App Intervention to Promote Cervical Cancer ScreeningUniversity of South Dakot...
NCT07573332
A Safety and Tolerability Study of CC- 97540 (BMS-086353) in Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica PatientsBristol-Myers SquibbNot Yet RecruitingPhase 1
NCT07573332Not Yet Recruiting
Phase 1
A Safety and Tolerability Study of CC- 97540 (BMS-086353) in Anti-Aquaporin 4 An...Bristol-Myers Squibb
NCT07573358
Validation of Artificial Intelligence-Based Facial Paralysis Assessment in Patients With Bell's PalsyCairo UniversityNot Yet Recruiting
NCT07573358Not Yet Recruiting
—
Validation of Artificial Intelligence-Based Facial Paralysis Assessment in Patie...Cairo University
NCT07573306
Validation and Feasibility of Noninvasive Oxygen Delivery Index Monitoring in Cardiac Surgery PatientsUniversity of MinnesotaNot Yet Recruiting
NCT07573306Not Yet Recruiting
—
Validation and Feasibility of Noninvasive Oxygen Delivery Index Monitoring in Ca...University of Minnesota
NCT07572097
High-Frequency Irreversible Electroporation vs Standard of Care for Benign Prostatic HyperplasiaShanghai East HospitalNot Yet RecruitingNot Applicable
NCT07572097Not Yet Recruiting
Not Applicable
High-Frequency Irreversible Electroporation vs Standard of Care for Benign Prost...Shanghai East Hospital
NCT07572994
Evaluation of the Effect of Adding Sodium Bicarbonate to Lidocaine in the Treatment of Myofascial Pain SyndromeCairo UniversityNot Yet RecruitingNot Applicable
NCT07572994Not Yet Recruiting
Not Applicable
Evaluation of the Effect of Adding Sodium Bicarbonate to Lidocaine in the Treatm...Cairo University
NCT07573020
Influence of Acellular Dermal Matrix on Peri-implant Soft Tissue Phenotype and Marginal Bone LossMansoura UniversityCompletedNot Applicable
NCT07573020Completed
Not Applicable
Influence of Acellular Dermal Matrix on Peri-implant Soft Tissue Phenotype and M...Mansoura University
NCT07573228
Impact of Obesity on Microvascular Insulin Action and Cardiorespiratory Fitness in Type 1 DiabetesUniversity of VirginiaRecruitingNot Applicable
NCT07573228Recruiting
Not Applicable
Impact of Obesity on Microvascular Insulin Action and Cardiorespiratory Fitness...University of Virginia
NCT07573748
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospital of Huai'anNot Yet RecruitingNot Applicable
NCT07573748Not Yet Recruiting
Not Applicable
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospi...
NCT07572448
The Relationship Between Nurses' Perception Of Safety Culture And Patients' Sense Of SafetyUludag UniversityNot Yet Recruiting
NCT07572448Not Yet Recruiting
—
The Relationship Between Nurses' Perception Of Safety Culture And Patients' Sens...Uludag University
NCT07572045
Promoting Interventions for Climate Change to Upscale Resilience in District BadinDr Jai Kumar DasNot Yet RecruitingNot Applicable
NCT07572045Not Yet Recruiting
Not Applicable
Promoting Interventions for Climate Change to Upscale Resilience in District Bad...Dr Jai Kumar Das
NCT07572591
Ultrasound for Peripheral Nerve ModulationStanford UniversityNot Yet RecruitingNot Applicable
NCT07572591Not Yet Recruiting
Not Applicable
Ultrasound for Peripheral Nerve ModulationStanford University
NCT07572006
A Study of JNJ-95804306 for Relapsed or Refractory Hematological MalignanciesJanssen Research & Development, LLCNot Yet RecruitingPhase 1
NCT07572006Not Yet Recruiting
Phase 1
A Study of JNJ-95804306 for Relapsed or Refractory Hematological MalignanciesJanssen Research & Develo...
Result Breakdown
Not yet recruiting15 (75%)
Recruiting4 (20%)
Completed1 (5%)
not_applicable10 (50%)
Not Specified4 (20%)
Phase 13 (15%)
Phase 31 (5%)
Phase 41 (5%)
Phase 21 (5%)